Scarica l'app Stockscreener
32.97
0.02%
0.018
Precedente Chiudi:
$32.95
Aprire:
$32.91
Volume 24 ore:
418.19K
Relative Volume:
0.17
Capitalizzazione di mercato:
$4.12B
Reddito:
$1.12B
Utile/perdita netta:
$5.00M
Rapporto P/E:
3,296.80
EPS:
0.01
Flusso di cassa netto:
$-383.00M
1 W Prestazione:
-2.01%
1M Prestazione:
-6.40%
6M Prestazione:
+111.25%
1 anno Prestazione:
+169.46%
Intervallo 1D:
$32.66
$33.27
Intervallo di 1 settimana:
$31.70
$33.67
Portata 52W:
$7.62
$38.00
Indivior Plc Stock (INDV) Company Profile
Nome
Indivior Plc
Settore
Telefono
804-379-1090
Indirizzo
234 BATH ROAD, SLOUGH, BERKSHIRE
Confronta INDV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
32.97 | 4.12B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
126.89 | 54.31B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.08 | 51.02B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.11B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.59 | 35.98B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
471.94 | 20.15B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-22 | Ripresa | Jefferies | Buy |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-07-23 | Iniziato | Piper Sandler | Overweight |
| 2024-04-03 | Iniziato | Craig Hallum | Buy |
| 2023-07-13 | Iniziato | Northland Capital | Outperform |
Mostra tutto
Indivior Plc Borsa (INDV) Ultime notizie
Indivior’s 2026 Revenue Guidance Tightens Expectations Might Change The Case For Investing In Indivior (INDV) - Yahoo Finance
Aug Selloffs: Can Indivior PLC stock outperform in a bear marketJuly 2025 Technicals & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Indivior PLC: Can a Focused Addiction-Treatment Specialist Win the Next Decade of Mental Health Phar - AD HOC NEWS
Grail and Indivior PLC come out on top in healthcare quant picks ahead of Q4 earnings - MSN
Market Wrap: Will WNEB outperform small cap indexes2025 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
Indivior (NASDAQ:INDV) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
Indivior PLC: How a Specialist Addiction Franchise Is Quietly Rebuilding a Global Pharma Contender - AD HOC NEWS
Indivior (INDV) Price Target Increased by 13.21% to 43.71 - Nasdaq
Q1 Earnings Forecast for Indivior Issued By HC Wainwright - MarketBeat
Portfolio Update: Is now the right time to enter Indivior PLCJuly 2025 Chart Watch & Accurate Entry/Exit Alerts - baoquankhu1.vn
Indivior PLC (INDV) Stock Analysis: Exploring a 24% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Aug Setups: Does Indivior PLC stock trade at a discount to peersMarket Activity Summary & Safe Capital Growth Tips - Bộ Nội Vụ
Risks Report: Will Indivior PLC stock remain a Wall Street favorite2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - Bộ Nội Vụ
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes - Finviz
HC Wainwright Estimates Indivior's Q2 Earnings (NASDAQ:INDV) - MarketBeat
51,426 Shares in Indivior PLC $INDV Purchased by KLP Kapitalforvaltning AS - MarketBeat
Volume Recap: Is Indivior PLC forming higher highs and higher lows2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn
TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug - Finviz
Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus - Yahoo Finance
Indivior stock price target raised to $48 from $35 at H.C. Wainwright - Investing.com Nigeria
INDV: Analyst Raises Price Target to $48.00, Maintains Buy Ratin - GuruFocus
Naloxone Market Is Going to Boom |EMERGENT, Indivior PLC, Akorn, Inc - openPR.com
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance - Finviz
Indivior (NasdaqGS:INDV) Valuation Check After Strong Long Term Returns And Recent Price Consolidation - Yahoo Finance
Indivior PLCOrdinary Shares (NQ: INDV - FinancialContent
Indivior forecasts 11% SUBLOCADE growth, 35% EBITDA increase for 2026 By Investing.com - Investing.com Nigeria
Craig-Hallum raises Indivior stock price target to $50 on strong 2026 outlook - Investing.com Nigeria
Aug Closing: Why hedge funds are buying Indivior PLC stockWall Street Watch & Safe Entry Trade Signal Reports - moha.gov.vn
Can Indivior PLC stock double in next 5 years2025 Volume Leaders & Safe Entry Point Alerts - ulpravda.ru
Why Indivior PLC (2IVB) stock is a strong analyst pickWeekly Risk Summary & Safe Entry Point Identification - ulpravda.ru
Why retail investors pile into Indivior PLC stockJuly 2025 Momentum & Fast Moving Market Watchlists - ulpravda.ru
Is Indivior PLC stock a top pick in earnings season2025 Macro Impact & Fast Exit Strategy with Risk Control - ulpravda.ru
What margin trends mean for Indivior PLC stockWeekly Trade Report & Real-Time Chart Pattern Alerts - ulpravda.ru
GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug - Finviz
Published on: 2026-01-08 20:56:58 - ulpravda.ru
How Indivior PLC stock performs during Fed tightening cycles2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
What analyst consensus says on Indivior PLC stock2025 AllTime Highs & Daily Technical Stock Forecast Reports - ulpravda.ru
Indivior Issues FY 2026 Financial Guidance - Nasdaq
Indivior shares rise after FY26 guidance tops consensus expectations By Investing.com - Investing.com Nigeria
Indivior PLC Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Indivior Expects Up to $1.20 Billion in 2026 Net Revenue - MarketScreener
(INDV) Indivior Expects 2026 Revenue Range $1.13B$1.2B, vs. FactSet Est of $1.19B - MarketScreener
Indivior forecasts 11% SUBLOCADE growth, 35% EBITDA increase for 2026 - Investing.com
Indivior PLC Announces Full-Year 2026 Financial Guidance and Business Highlights - Quiver Quantitative
Indivior : Financial Document - MarketScreener
Indivior PLC Provides 2026 Financial Guidance and Business Update - TradingView — Track All Markets
Indivior Provides Full-Year 2026 Financial Guidance and Business Update - Bluefield Daily Telegraph
Humphreys Keith buys Indivior (INDV) shares worth $27,429 By Investing.com - Investing.com Australia
Indivior price target raised to $40 from $30 at Northland - MSN
Is Indivior (NasdaqGS:INDV) Still Attractive After A 192% One Year Share Price Jump - Yahoo Finance
Indivior (NASDAQ:INDV) Director Purchases $27,427.25 in Stock - MarketBeat
Indivior Plc Azioni (INDV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Indivior Plc Azioni (INDV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Humphreys Keith | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
5,802 |
| NINIVAGGI DANIEL A | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
16,923 |
| Stejbach Mark | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
16,847 |
| Wheadon David E. | Director |
Jan 05 '26 |
Buy |
35.39 |
1,771 |
62,680 |
14,395 |
2.05%
7.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):